FDA approves antiviral drug remdesivir as coronavirus treatment

Published



The Food and Drug Administration granted approval of remdesivir, an antiviral drug from Gilead Sciences and a treatment for COVID-19.

The drug, sold under the name Veklury, will be used for hospitalized COVID-19 patients, Gilead said. It is the first coronavirus disease treatment to receive FDA approval.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.